Clinical features of the selected studies | Download Table
Pharmacokinetic data on drug-drug interactions of delamanid | Download Table
RNTCP guideline for use of Delamanid in DR-TB in India 2018
Deltyba, INN-Delamanid
Frontiers | Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis | NEJM
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Semantic Scholar
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis | European Respiratory Society
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition
Delamanid
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo | Drug Metabolism & Disposition
Journal of the Association of Physicians of India - JAPI
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study - The Lancet
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink
An Activist's Guide to Delamanid (Deltyba) – Treatment Action Group
Figures and data in The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis | eLife
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis | NEJM
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration | SpringerLink
